Verve Therapeutics
VERV
#7015
Rank
NZ$0.70 B
Marketcap
$8.27
Share price
5.43%
Change (1 day)
-58.51%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -NZ$0.37 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are NZ$20.64 Million. In 2023 the company made an earning of -NZ$0.39 Billion a decrease over its 2022 earnings that were of -NZ$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.37 Billion-4.24%
2023 -NZ$0.39 Billion34.67%
2022 -NZ$0.29 Billion90.3%
2021 -NZ$0.15 Billion114.31%
2020 -NZ$69.3 Million